PAR-21-173 - Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Applications of Data Science in Translational Dental, Oral, and Craniofacial Research |
NOT-DE-23-002 |
NIDCR
|
Jun 12, 2023 |
May 8, 2026
|
K43, K18, R01, K08, K99/R00, K01, K23, R21, F99/K00, F32, F31, R16, G11, K22, R15, R03, UE5, U01, R13, K25, K02, F30, F33, D43, D71 |
Notice of Special Interest (NOSI): Optimization of Data Storage and Utilization for the Sequence Read Archive (SRA) |
NOT-GM-23-015 |
NIGMS , NLM , ODSS
|
Dec 14, 2022 |
Dec 19, 2025
|
R41/R42, R43/R44, R01, K08, RM1, R21, K25, K99/R00, K23, F30, F32, F33, F31, R16, R35, R15 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of NHLBI Participation in PAR-21-173 - "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)" |
NOT-HL-21-043 |
NHLBI
|
Dec 21, 2021 |
n/a
|
R16 |
|